The TouCAHn trial is an open-label, global, Phase 2 study designed to evaluate the efficacy, safety, and pharmacokinetics of ...
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.
MERIDIAN, Calif. — The mother of an 11-year-old boy in Sutter County was arrested Sunday in connection with her child's death ...
As the U.S. stock market experiences a notable upswing, with the S&P 500 and Nasdaq extending their winning streaks, investors are keenly observing growth opportunities amid this positive momentum. In ...
Growth stocks are equity shares likely to outperform their peers and the broader market. Here's a list of stocks that contain investment potential to beef up your portfolio.
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Strategy” third quarter 2024 ...
Many of these conditions are associated with the development of Cushing's syndrome. In general, healthcare providers will work toward getting patients weaned off steroid drugs such as prednisone as ...
Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report). The ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified ...
Analyst David Lebowitz from Citi maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report) and keeping the price target at ...